Deep sequencing reveals distinct microRNA-mRNA signatures that differentiate pancreatic neuroendocrine tumor from non-diseased pancreas tissue
Abstract Background Only a limited number of biomarkers guide personalized management of pancreatic neuroendocrine tumors (PanNETs). Transcriptome profiling of microRNA (miRs) and mRNA has shown value in segregating PanNETs and identifying patients more likely to respond to treatment. Because miRs a...
Saved in:
| Main Authors: | N Matyasovska, N Valkova, M Gala, S Bendikova, A Abdulhamed, V. Palicka, Neil Renwick, Pavol Čekan, Evan Paul |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14043-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01) -
mRNA turnover rate limits siRNA and microRNA efficacy
by: Erik Larsson, et al.
Published: (2010-11-01) -
Nuclear mRNA export
by: Chen Suli, et al.
Published: (2024-09-01) -
Mitigating host microRNA interference to enhance mRNA vaccine efficacy in public health interventions
by: Tielong Xu, et al.
Published: (2025-04-01) -
Rational optimization of glycoprotein E (gE)-encoding mRNA for improved Varicella-zoster virus mRNA vaccine development
by: Lulu Huang, et al.
Published: (2024-12-01)